News & Updates
Filter by Specialty:
![[MK TEST DO NOT TOUCH] Deuruxolitinib helps restore crowning glory in alopecia areata](https://sitmspst.blob.core.windows.net/images/articles/thriveaa1-and-thrive-aa2-87e6d5ec-94c6-405b-a380-d331c4dcc5fc-square.jpg)
[MK TEST DO NOT TOUCH] Deuruxolitinib helps restore crowning glory in alopecia areata
19 Aug 2024
byAudrey Abella
Pooled analyses of the phase III THRIVEAA1 and THRIVE-AA2 trials underpin the potential of the selective oral JAK* 1/2 inhibitor deuruxolitinib to effectively and safely reverse hair loss in adults with moderate-to-severe alopecia areata (AA).
[MK TEST DO NOT TOUCH] Deuruxolitinib helps restore crowning glory in alopecia areata
19 Aug 2024
![[MK TEST DO NOT TOUCH] In-home phototherapy delivers promising results in psoriasis](https://sitmspst.blob.core.windows.net/images/articles/in-home-phototherapy-delivers-promising-results-in-psoriasis-7365fdf6-9f6d-4e11-9878-f5b5493f8bac-square.jpg)
![[MK TEST DO NOT TOUCH] Trifarotene clears acne battle scars](https://sitmspst.blob.core.windows.net/images/articles/trifarotene-shown-to-improve-acne-and-related-sequelae-scars-pigmentation-cff39adb-88b8-415c-8b5f-5751a5e5465c-square.jpg)
[MK TEST DO NOT TOUCH] Trifarotene clears acne battle scars
18 Mar 2024
byAudrey Abella
Individuals dealing with the stubborn scars and hyperpigmentation left behind by acne may find benefit in trifarotene cream – the newest among the new generation of topical retinoids approved for acne treatment, according to the findings of two vehicle-controlled, phase IV studies presented at AAD 2024.
